Sinoma Science & TechnologyLtd Toekomstige groei
Future criteriumcontroles 4/6
Sinoma Science & TechnologyLtd zal naar verwachting groeien in winst en omzet met respectievelijk 31.1% en 14.2% per jaar. De winst per aandeel zal naar verwachting groeien met 30.4% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 8.6% zijn.
Belangrijke informatie
31.1%
Groei van de winst
30.4%
Groei van de winst per aandeel
Chemicals winstgroei | 39.9% |
Inkomstengroei | 14.2% |
Toekomstig rendement op eigen vermogen | 8.6% |
Dekking van analisten | Good |
Laatst bijgewerkt | 18 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
Sinoma Science & TechnologyLtd's (SZSE:002080) Problems Go Beyond Weak Profit
Nov 04Even With A 44% Surge, Cautious Investors Are Not Rewarding Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Performance Completely
Oct 08Should You Investigate Sinoma Science & Technology Co.,Ltd. (SZSE:002080) At CN¥9.99?
Sep 25Estimating The Fair Value Of Sinoma Science & Technology Co.,Ltd. (SZSE:002080)
Sep 10Bearish: Analysts Just Cut Their Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Revenue and EPS estimates
Aug 26Sinoma Science & TechnologyLtd (SZSE:002080) Might Be Having Difficulty Using Its Capital Effectively
Aug 21These 4 Measures Indicate That Sinoma Science & TechnologyLtd (SZSE:002080) Is Using Debt Extensively
Jul 25Why Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Could Be Worth Watching
Jun 10Sinoma Science & TechnologyLtd (SZSE:002080) Has Announced That Its Dividend Will Be Reduced To CN¥0.56
May 27Capital Allocation Trends At Sinoma Science & TechnologyLtd (SZSE:002080) Aren't Ideal
May 13Are Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Investors Paying Above The Intrinsic Value?
Apr 14Earnings Troubles May Signal Larger Issues for Sinoma Science & TechnologyLtd (SZSE:002080) Shareholders
Mar 31Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Price Is Right But Growth Is Lacking
Mar 14Should You Think About Buying Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Now?
Feb 28Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 32,672 | 2,132 | 925 | 5,873 | 9 |
12/31/2025 | 29,025 | 1,727 | -617 | 4,518 | 10 |
12/31/2024 | 23,910 | 1,112 | -1,619 | 4,669 | 6 |
9/30/2024 | 24,388 | 1,126 | 159 | 6,434 | N/A |
6/30/2024 | 24,050 | 1,298 | -3,152 | 4,436 | N/A |
3/31/2024 | 25,276 | 2,027 | -3,806 | 4,305 | N/A |
12/31/2023 | 25,889 | 2,224 | -2,945 | 4,820 | N/A |
9/30/2023 | 26,317 | 2,836 | -5,146 | 2,289 | N/A |
6/30/2023 | 26,757 | 3,079 | -3,623 | 3,021 | N/A |
3/31/2023 | 26,196 | 3,253 | -2,290 | 3,227 | N/A |
1/1/2023 | 25,814 | 3,574 | -1,632 | 3,031 | N/A |
9/30/2022 | 23,462 | 3,172 | 205 | 3,415 | N/A |
6/30/2022 | 22,372 | 3,413 | 697 | 2,984 | N/A |
3/31/2022 | 20,934 | 3,518 | 603 | 2,352 | N/A |
12/31/2021 | 20,295 | 3,373 | 1,869 | 3,672 | N/A |
9/30/2021 | 20,522 | 3,159 | 1,482 | 3,255 | N/A |
6/30/2021 | 20,600 | 2,977 | 1,664 | 3,800 | N/A |
3/31/2021 | 19,999 | 2,387 | 516 | 2,986 | N/A |
12/31/2020 | 18,865 | 2,040 | 560 | 3,273 | N/A |
9/30/2020 | 17,038 | 1,889 | 234 | 3,295 | N/A |
6/30/2020 | 15,148 | 1,634 | 148 | 3,084 | N/A |
3/31/2020 | 13,821 | 1,405 | 1,179 | 3,557 | N/A |
12/31/2019 | 13,590 | 1,380 | 793 | 2,970 | N/A |
9/30/2019 | 13,148 | 1,167 | 157 | 2,021 | N/A |
6/30/2019 | 12,732 | 1,165 | -153 | 1,621 | N/A |
3/31/2019 | 11,985 | 962 | -574 | 1,378 | N/A |
12/31/2018 | 11,411 | 894 | -147 | 1,564 | N/A |
9/30/2018 | 10,807 | 913 | -1,203 | 630 | N/A |
6/30/2018 | 10,504 | 778 | N/A | 771 | N/A |
3/31/2018 | 10,289 | 778 | N/A | 654 | N/A |
12/31/2017 | 10,237 | 767 | N/A | 770 | N/A |
9/30/2017 | 9,695 | 699 | N/A | 1,622 | N/A |
6/30/2017 | 9,386 | 539 | N/A | 1,161 | N/A |
3/31/2017 | 9,205 | 499 | N/A | 1,118 | N/A |
12/31/2016 | 8,700 | 438 | N/A | 1,082 | N/A |
9/30/2016 | 8,785 | 436 | N/A | 858 | N/A |
6/30/2016 | 8,813 | 568 | N/A | 1,103 | N/A |
3/31/2016 | 9,728 | 678 | N/A | 861 | N/A |
12/31/2015 | 9,176 | 630 | N/A | 1,399 | N/A |
9/30/2015 | 8,216 | 613 | N/A | 654 | N/A |
6/30/2015 | 6,989 | 451 | N/A | 767 | N/A |
3/31/2015 | 4,837 | 194 | N/A | 944 | N/A |
12/31/2014 | 4,424 | 152 | N/A | 382 | N/A |
9/30/2014 | 3,981 | 108 | N/A | 601 | N/A |
6/30/2014 | 3,680 | 92 | N/A | 731 | N/A |
3/31/2014 | 3,545 | 96 | N/A | 88 | N/A |
12/31/2013 | 3,443 | 108 | N/A | 253 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei 002080 ( 31.1% per jaar) ligt boven de spaarquote ( 2.8% ).
Winst versus markt: De winst van 002080 ( 31.1% per jaar) zal naar verwachting sneller groeien dan de CN markt ( 26.1% per jaar).
Hoge groeiwinsten: De winst van 002080 zal naar verwachting de komende 3 jaar aanzienlijk groeien.
Omzet versus markt: De omzet van 002080 ( 14.2% per jaar) zal naar verwachting sneller groeien dan de markt CN ( 13.8% per jaar).
Hoge groei-inkomsten: De omzet van 002080 ( 14.2% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen 002080 zal naar verwachting over 3 jaar laag zijn ( 8.6 %).